pharmaceutical investing Bio-Path Announces Clinical Update to Interim Analysis of Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia
Aptevo Therapeutics Doses First Patient in Phase 1/1b Clinical Trial of Lead Next-Generation Bispecific Antibody APVO436
Chi-Med Initiates a Phase I Trial of HMPL-523 in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia in China
Silver Hammer Announces Acquisitions of Stroud Resources and Silvermark Resources and Brokered Financing; Eric Sprott to Become Cornerstone Shareholder
QIMC Reports Record 24.3% Clean Natural Hydrogen at Bennett Hill DDH-26-04 and Begins Technical Evaluation of Pilot-Scale Development Pathway and Clean Energy Generation
